Engineering functional human vasculature: iPSC-derived vascular cells and organoids for disease modeling and translation
Vascular Pharmacology · 2026
DOI: 10.1016/j.vph.2026.107683 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Chonggui Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, China. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Organoids, Tissue Engineering, Endothelial Cells. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Human vascular function depends on tightly coordinated structural, mechanical, and cellular interactions, yet these features remain difficult to recapitulate in vitro. Induced pluripotent stem cells (iPSCs) enable efficient generation of vascular cell types, including endothelial cells, smooth muscle cells, and pericytes, but current systems often lack functional maturity and physiological relevance. Recent advances in vascular organoid engineering provide new opportunities to address this limitation. By integrating self-organization, co-culture, and bioengineering approaches, iPSC-derived systems can form three-dimensional vascular networks with increasing physiological relevance. Emerging evidence from studies of iPSC-derived vascular systems, spanning both two-dimensional differentiation models and three-dimensional organoid platforms, highlights the critical roles of hemodynamic cues, including shear stress and perfusion, together with metabolic and immune signaling, in driving the coordinated maturation of endothelial and mural compartments. These platforms enable modeling of key vascular pathologies, including inflammation, vascular remodeling, and barrier dysfunction, while gene editing further facilitates mechanistic investigation in patient-specific contexts. Together, iPSC-derived vascular systems provide a scalable and physiologically relevant platform for disease modeling, drug discovery, and regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, China. Electronic address: liyan.gong@ihm.ac.cn.
Zitieren
APA
Jiang, C., Cui, P., & Gong, L. (2026). Engineering functional human vasculature: iPSC-derived vascular cells and organoids for disease modeling and translation. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107683
Vancouver
Jiang C, Cui P, Gong L. Engineering functional human vasculature: iPSC-derived vascular cells and organoids for disease modeling and translation. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107683
BibTeX
@article{Jiang2026,
author = {Jiang, Chonggui and Cui, Pan and Gong, Liyan},
title = {Engineering functional human vasculature: iPSC-derived vascular cells and organoids for disease modeling and translation},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107683}
}
EUVIMED